Trials / Conditions / Mantle Cell Lymphoma Recurrent
Mantle Cell Lymphoma Recurrent
5 registered clinical trials studyying Mantle Cell Lymphoma Recurrent.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL NCT05360238 | Mustang Bio | Phase 1 / Phase 2 |
| Terminated | Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product NCT05645744 | Mustang Bio | — |
| Active Not Recruiting | Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantl NCT04234061 | Peter MacCallum Cancer Centre, Australia | Phase 2 |
| Terminated | A Phase II Study of Doxycycline in Relapsed NHL NCT02086591 | University of Rochester | Phase 2 |
| Unknown | Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma NCT01322776 | Sun Yat-sen University | Phase 1 / Phase 2 |